Evidence map›Paper›PMID 9050888›Full record

Trial reportProceedings of the National Academy of Sciences of the United States of America1997

Glutathione deficiency is associated with impaired survival in HIV disease.

L A Herzenberg, S C De Rosa, J G Dubs, M Roederer, M T Anderson, S W Ela, S C Deresinski, L A Herzenberg

Open access · greenAbstract readClinical TrialRandomized Controlled Trial
In one paragraph

Trial report in Proceedings of the National Academy of Sciences of the United States of America, 1997. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 146 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
146citing papers in PubMed, 1 pooled it
40.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

146 citing papers in PubMed, 1 synthesis or guideline pooled it, 673 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Trial
  6. Article
  7. Article
  8. Glutathione impacts bothbioRxiv : the preprint server for biology · 2026
    Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. MercuryMikrochimica acta · 2024
    Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article

86 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

L A HerzenbergDepartment of Genetics, Stanford University Medical School, CA 94305-5125, USA.
S C De Rosa
J G Dubs
M Roederer
M T Anderson
S W Ela
S C Deresinski
L A Herzenberg
Stanford University · US

Funding

MOLECULAR &CELLULAR IMMUNOBIOLOGYT32AI007290 · NIAID · STANFORD UNIVERSITY · PI Sean Curtis Bendall, Olivia M Martinez · 1985 to 2026
$27.0M
GENETICS OF IMMUNOGLOBULINS AND LYMPHOCYTE MOLECULESR35CA042509 · NCI · STANFORD UNIVERSITY · PI HERZENBERG, LEONARD A · 1986 to 2000
$71k
FACS-PENGUIN: KNOWLEDGE BASE SUPPORT FOR FLOW CYTOMETRYR01LM004836 · NLM · STANFORD UNIVERSITY · PI HERZENBERG, LEONORE A. · 1989 to 1999
–
NCI NIH HHS CA-42509NIAID NIH HHS 5T32 AI-007290NIAID NIH HHS T32 AI007290NLM NIH HHS LM-04836
6 · The paper itself

Abstract

Glutathione (GSH), a cysteine-containing tripeptide, is essential for the viability and function of virtually all cells. In vitro studies showing that low GSH levels both promote HIV expression and impair T cell function suggested a link between GSH depletion and HIV disease progression. Clinical studies presented here directly demonstrate that low GSH levels predict poor survival in otherwise indistinguishable HIV-infected subjects. Specifically, we show that GSH deficiency in CD4 T cells from such subjects is associated with markedly decreased survival 2-3 years after baseline data collection (Kaplan-Meier and logistic regression analyses, P < 0.0001 for both analyses). This finding, supported by evidence demonstrating that oral administration of the GSH prodrug N-acetylcysteine replenishes GSH in these subjects and suggesting that N-acetylcysteine administration can improve their survival, establishes GSH deficiency as a key determinant of survival in HIV disease. Further, it argues strongly that the unnecessary or excessive use of acetaminophen, alcohol, or other drugs known to deplete GSH should be avoided by HIV-infected individuals.

Indexed as

AcetylcysteineBiomarkersCD4-Positive T-LymphocytesCell SurvivalCohort StudiesDisease ProgressionGlutathioneHIV InfectionsHumansPyrazolesRegression AnalysisSurvival AnalysisSurvival RateAcetylcysteineBiomarkersGlutathionemonochlorobimanePyrazoles

Identifiers

PMID9050888
PMCPMC20026
OpenAlexW2094321502

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.